Safety and Efficacy of Extended Therapy with [

PSMA therapy mCRPC prostate cancer

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 May 2024
Historique:
received: 22 12 2023
revised: 25 03 2024
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 2 5 2024
Statut: aheadofprint

Résumé

Prospective results have demonstrated favorable safety and efficacy of [

Identifiants

DOI: 10.2967/jnumed.123.267321 PMID: 38697669
pubmed: 38697669
pii: jnumed.123.267321
doi: 10.2967/jnumed.123.267321
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Robert Seifert (R)

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany.

Tugce Telli (T)

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.

Constantin Lapa (C)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.

Mélanie Desaulniers (M)

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.

Turkay Hekimsoy (T)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Bavarian Cancer Research Center, Erlangen, Germany.

Wolfgang A Weber (WA)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Bavarian Cancer Research Center, Erlangen, Germany.

Christian Pfob (C)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.

Boris Hadaschik (B)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.
Department of Urology, University Hospital Essen, Essen, Germany; and.

Martin Bögemann (M)

West German Cancer, University Hospital Essen, Essen, Germany.
Department of Urology, University Hospital Münster, Münster, Germany.

Michael Schäfers (M)

West German Cancer, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany.

Ken Herrmann (K)

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.

Kambiz Rahbar (K)

West German Cancer, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany.

Matthias Eiber (M)

German Cancer Consortium, University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Bavarian Cancer Research Center, Erlangen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany; wolfgang.fendler@uk-essen.de.
German Cancer Consortium, University Hospital Essen, Essen, Germany.
West German Cancer, University Hospital Essen, Essen, Germany.

Classifications MeSH